Not Yet Recruiting
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation
NCT06015568
- Conditions
- Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
- Locations
-
- The first affiliated hospital of bengbu medical college Bengbu, Anhui, China
- Hunan cancer hospital Changsha, Hunan, China
- Shanghai chest hospital Shanghai, China